High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.

Source:http://linkedlifedata.com/resource/pubmed/id/9070490

Cancer 1997 Mar 15 79 6 1129-37

Download in:

View as

General Info

PMID
9070490